Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
Authors:
Open Access
- 24 March 2017
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 34 (5) , 1087-1096
Abstract
Introduction This study aimed to demonstrate the clinical utility of non-invasive multigene Cxbladder urine tests in reducing the overall number of diagnostic tests and invasive procedures used in the clinical evaluation of patients presenting with microhematuria, a key symptom of urothelial carcinoma (UC). There is a belief that using non-invasive molecular diagnostic tests in patients with hematuria may lead to patients undergoing unnecessary and costly invasive procedures that can cause adverse events and decrease patient quality of life. The objective of this study was to determine whether or not this was the case, using Cxbladder. Methods Data from 396 patient-by-urologist interactions generated 792 decision points from a standardized cohort of 33 patients evaluated by 12 urologists. Participant physicians recommended a selection of tests and procedures based on referral data, then reviewed and amended their recommendations in the context of diagnostic information from Cxbladder used in the Triage and Triage and Detect clinical modalities. Results All urologists changed their diagnostic behavior in at least one patient case with the addition of Cxbladder results. The total number of diagnostic procedures was reduced by 5% and 25% following disclosure of results from Cxbladder in the Triage and the Triage and Detect modalities, respectively. The total number of requested invasive procedures was reduced from 425 at referral to 379 (−11%) and 292 (−31%) following disclosure of Cxbladder information in the Triage and Triage and Detect modalities, respectively. Conclusions Urologists made compelling changes to their clinical decision-making when they were provided with Cxbladder results for patients presenting with hematuria. Cxbladder provides an increase in clinical utility by focusing the use of invasive diagnostic procedures to appropriate patients, reducing both the total number and number of invasive procedures used in the clinical management of patients with hematuria, thereby improving the diagnostic experience and outcomes for patients. Funding Pacific Edge Ltd.Keywords
Funding Information
- Pacific Edge Ltd.
This publication has 26 references indexed in Scilit:
- The Risk of Urinary Tract Infection after Flexible Cystoscopy in Patients with Bladder Tumor Who Did Not Receive Prophylactic AntibioticsJournal of Urology, 2015
- Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with CancerClinical Cancer Research, 2014
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- Current perspectives in bladder cancer managementInternational Journal Of Clinical Practice, 2012
- A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with HematuriaJournal of Urology, 2012
- 1236 RE-DESIGN OF A HAEMATURIA CLINIC: ASSESSMENT OF 2436 HAEMATURIA PATIENTSJournal of Urology, 2011
- Is Routine Urine Cytology Useful in the Haematuria Clinic?The Annals of The Royal College of Surgeons of England, 2008
- A PROSPECTIVE ANALYSIS OF 1,930 PATIENTS WITH HEMATURIA TO EVALUATE CURRENT DIAGNOSTIC PRACTICEJournal of Urology, 2000
- Microscopic haematuria: urological investigation using a standard protocolBritish Journal of Urology, 1996
- Evaluation of Hematuria in AdultsJAMA, 1990